Shiro Mita
Fondatore presso M's Science Corp.
Posizioni attive di Shiro Mita
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
M's Science Corp.
 M's Science Corp. Miscellaneous Commercial ServicesCommercial Services M's Science Corp. engages in the research and development of drugs for the treatment of central nervous system (CNS) disorders and ocular diseases. It develops Cutamesine, an orally active compound that enhances neuroregeneration and facilitates the recovery of damaged CNS tissues from stress or ischemia-induced insults. The firm also develops therapeutic drugs for oncology. The company was founded by Shiro Mita in November 2000 and is headquartered in Kobe, Japan. | Direttore/Membro del Consiglio | 01/11/2000 | - |
| Fondatore | 01/11/2000 | - |
Storia della carriera di Shiro Mita
Precedenti posizioni note di Shiro Mita
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD. | Direttore/Membro del Consiglio | 01/03/2016 | - |
| SANTEN PHARMACEUTICAL CO., LTD. | Direttore/Membro del Consiglio | - | - |
| ACUCELA INC | Direttore/Membro del Consiglio | 01/05/2015 | - |
| Keio University | Corporate Officer/Principal | - | - |
Formazione di Shiro Mita
| University of Tokyo | Doctorate Degree |
Statistiche
Distribuzione geografica
| Giappone | 6 |
| Stati Uniti | 2 |
Posizioni
| Director/Board Member | 4 |
| Doctorate Degree | 1 |
| Corporate Officer/Principal | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| SANTEN PHARMACEUTICAL CO., LTD. | Health Technology |
| KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD. | Health Technology |
| Aziende private | 2 |
|---|---|
M's Science Corp.
M's Science Corp. Miscellaneous Commercial ServicesCommercial Services M's Science Corp. engages in the research and development of drugs for the treatment of central nervous system (CNS) disorders and ocular diseases. It develops Cutamesine, an orally active compound that enhances neuroregeneration and facilitates the recovery of damaged CNS tissues from stress or ischemia-induced insults. The firm also develops therapeutic drugs for oncology. The company was founded by Shiro Mita in November 2000 and is headquartered in Kobe, Japan. | Commercial Services |
Acucela, Inc.
 Acucela, Inc. Pharmaceuticals: MajorHealth Technology Acucela, Inc. operates as a clinical-stage biotechnology company. It discovers and develops novel therapeutics to treat and show the progression of sight-threatening ophthalmic diseases. Its pipeline includes drug candidates and therapeutics for the treatment of age related macular degeneration, cataracts, presbyopia, diabetic retinopathy, retinitis igmentosa and Stargardt disease. The company was founded by Ryo Kubota in April 2002 and is headquartered in Seattle, WA. | Health Technology |
- Borsa valori
- Insiders
- Shiro Mita
- Esperienza
